Saudi Arabia approves more jabs, enabling entry of Umrah pilgrims vaccinated with Sinopharm
Saudi Arabia on Tuesday approved two more Covid-19 vaccines -- Sinovac and Sinopharm, Arab News said.
With this approval, uncertainty over performing Umrah hajj by Bangladeshis inoculated with Sinopharm vaccine was over, a top official of Religious Affairs Ministry told The Daily Star over phone.
The Kingdom had earlier approved four vaccines: Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, and Moderna.
The Ministry of Health of Saudi Arabia said it was possible for those who had completed their vaccination programme with Sinopharm or Sinovac to be accepted in the Kingdom, provided they had received a booster shot of a vaccine that was approved in the country, Arab News has said.
It previously said that two doses of two different vaccines could be taken, according to international scientific studies that showed the safety and effectiveness of this approach in addressing the virus.
It added that, according to current recommendations, the second dose could be taken at least three weeks after the first.
People recovering from Covid-19 should receive two doses of the vaccine, the first being at least 10 days after infection with the second administered at least three weeks after.
If the infection occurred after receiving the first dose, the second dose could be administered at least 10 days after infection.
Comments